{"id":"tetraethylphthalamide","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"analetil","offLabel":[],"synonyms":["tetraethylphthalamide","analetil","geastigmol","geastimol"],"timeline":[],"approvals":[],"brandName":"Analetil","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a complex orchestra. Analetil is like a new instrument that's being introduced, but we don't know exactly how it fits in or what notes it plays. It's likely to affect the way cells communicate and work together, but we need more research to understand how.","oneSentence":"Analetil works by interacting with specific biological pathways, but the exact mechanism is unknown.","technicalDetail":"As a small molecule, Analetil is expected to interact with specific proteins or receptors, potentially modulating their activity or expression. However, the precise molecular mechanisms underlying its effects are currently unknown and require further investigation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3588","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=tetraethylphthalamide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:52:01.897023","biosimilars":[],"competitors":[],"genericName":"tetraethylphthalamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"22TJ09HM80","CHEBI":"CHEBI:135143","PUBCHEM_CID":"66526"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Analetil (tetraethylphthalamide) is a small molecule compound with unknown target and drug class. Its commercial status and approved indications are not available. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is unknown. Further research is needed to understand its potential therapeutic applications and safety profile. Its development and ownership information are also not publicly disclosed.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}